Cost-effectiveness of Prosorba column therapy for rheumatoid arthritis: a framework for analysis.
Apheresis with the Prosorba column is safe and effective for treating refractory rheumatoid arthritis. It also is resource intensive. Economic evaluation of Prosorba column therapy could help promote efficient use of this technology. This article describes a framework and the data requirements for a...
主要な著者: | Griffiths, R, Slurzberg, J |
---|---|
フォーマット: | Journal article |
言語: | English |
出版事項: |
2001
|
類似資料
-
Medical resource use and costs among rheumatoid arthritis patients receiving disease-modifying antirheumatic drug therapy.
著者:: Griffiths, R, 等
出版事項: (2000) -
Pathogenesis and therapy of rheumatoid arthritis.
著者:: Williams, R
出版事項: (2006) -
Cytokine therapy in rheumatoid arthritis.
著者:: Maini, R, 等
出版事項: (1996) -
Quality of Life and Cost Study of Rheumatoid Arthritis Therapy With Biological Medicines
著者:: Vladimira V. Boyadzieva, 等
出版事項: (2018-07-01) -
Pharmacoeconomic evaluation of costs of rheumatoid arthritis therapy with selected biological treatment
著者:: Krzysztof Kowalik, 等
出版事項: (2018-12-01)